Congestive heart failure in infancy and childhood;Herzinsuffizienz im kindesalter

Klinische Padiatrie

Volumn 211, Issue 1, 1999, Pages 1-10

  Schmaltz, Achim A ^a  

^a NONE

Author keywords

ACE inhibitors; Childhood; Digitalis; Heart failure; Regulatory mechanisms; Therapy

Indexed keywords

CATECHOLAMINE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

CHILD; CHILDHOOD DISEASE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; HUMAN; INFANT; INFANT DISEASE; REVIEW; THORAX RADIOGRAPHY;

EID: 0032919905     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043754     Document Type: Review

References (79)

1. 1 Achhammer, I.: Long-term efficacy and tolerance of torasemide in congestive heart failure. Prog. Pharmacol. Clin. Pharmacol. 8 (1990) 127-136
2. 2 Artman, M., T. P. Graham, N. Tenn: Congestive heart failure in infancy: Recognition and management, Am. Heart J. 6, (1982) 1040-1055
3. 3 Artman, M., T. P. Graham: Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am. Heart J. 113 (1987) 994-1005
4. 4 Baylen, B. G., G. Johnson, R. Tsang, L. Srivastava, S. Kaplan: The occurrence of hyperaldosteronism in infants with congestive heart failure. Am. J. Cardiol. 45 (1980) 305-310
5. 5 Beekman, R. H., A. P. Rocchini, M. Dick H, D. C. Crowley, A. Rosenthal: Vasodilator therapy in children: Acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation. Pediatrics 73 (1984) 43-51
6. 6 Beekman, R. H., A. P. Rocchini, A. Rosenthal: Hemodynamic effects of hydralazine in infants with a large ventricular septal defect. Circulation 65 (1992) 523-528
7. 7 Beekman, R. H., A. P. Roccini, A. Rosenthal: Hemodynamic effects of nitroprusside in infants with a large ventricular septal defect. Circulation 64 (1994) 553-558
8. 8 Benson, L. N., D. Bohn, J. F. Edmonds, R. L. Fortune, S. A. Price, W. G. Williams, R. D. Rowe: Nitroglycerin therapy in children with low cardiac index after heart surgery. Cardiovasc. Med. (1979) 207-215
9. 9 Benzing, G., J. A. Helmsworth, J. T. Schreiber, S. Kaplan: Nitroprusside and epinephrine for treatment of low output in children after open-heart surgery. Ann. Thorac. Surg. 27 (1979) 523-528
10. 10 Bermann, W. jr., S. M. Yabek, T. Dillon, C. Niland, S. Corlew, D. Christensen: Effects of digoxin in infants with a congested circulatory state due to a ventricular septal defect. N. Engl. J. Med. 308 (1983) 363-366
11. 11 Boucek, M. M., R. Chang, D. P. Synhorst: Hemodynamic consequences of inotropic support with digoxin or amrinone in lambs with ventricular septal defect. Pediatr. Res. 9 (1985) 887-891
12. 12 Boucek, M. M., R. Chang: Effects of captopril on the distribution of left ventricular output with ventricular septal defect. Pediatr. Res. 24 (1988) 499-503
13. 13 Brändle, M., T. Ehring, T. Neumann, G. Heusch: Keine positive Treppe am gesunden Herzen und keine negative Treppe am insuffizienten Herzen des chronisch instrumentierten, wachen Hundes. Z. Kardiol. 85, Suppl. (1996) 211
14. 14 Braunwald, E., E. H. Sonnenblick, J. Ross jr.: Mechanisms of cardiac contraction and relaxation. In: Braunwald, E. (ed.) Heart Disease. A textbook of cardiovascular medicine. 4th Ed. W. B. Saunders, Philadelphia (1992), pp. 351-392
15. 15 Brodde, O.-E., H. R. Zerkowski, N. Doetsch, S. Motomura, M. Khamssi, M. C. Michel: Myocardial beta-adrenoceptor changes in heart failure concomitant reduction in beta 1-and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J. Am. Coll. Cardiol. 14 (1989) 323
16. 16 Burkart, F., E. Erdmann, P. Hanrath, W. Kübler, E. Mutschler. G. Riegger, H. Scholz, H.-P. Schultheiß. Consensus-Konferenz: Therapie der chronischen Herzinsuffizienz. Z. Kardiol. 82 (1993) 200-206
17. 17 Carlson, K. J., D. C. Lee, A. H. Goroll, M. Leahy, R. A. Johnson: An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J. Chronic Dis. 38 (1985) 733-739
18. 18 Cleland, J. G. F., M. R. Bristow, E. Erdmann, W. J. Remme, K. Swedberg, F. Waagstein: Beta-blocking agents in heart failure. Should they be used and how? Eur. Heart J. 17 (1996) 1629-1639
19. 19 Cohn, J. N., T. B. Levine, M. T. Olivari, V. Garberg, D. Lura, G. S. Francis, A. B. Simon, T. Rector: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311 (1984) 819-823
20. 20 CONSENSUS Trial Study Group: Effects of enalapril on mortality and morbitiy in severe heart failure. N. Engl. J. Med. 316 (1987) 1429-1435
21. 21 Cowie, M. R., A. Mosterd, D. A. Wood, J. W. Deckers, P. A. Poole-Wilson, C. G. Sutton, D. E. Grobbee: The epidemiology of heart failure. Eur. Heart J. 18 (1997) 208-225
22. 22 Denolin, H., H. Kuhn, H. Krayenbuehl, F. Loogen, A. Reale: The definition of heart failure. Eur. Heart J. 4 (1983) 445-448
23. 23 Digitalis Investigation Group (DIG): The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 306 (1997) 525-533
24. 24 Döhlemann, Chr., K. Bühlmeyer: Ergebnisse vergleichender oraler und intravenöser Digitalistherapie bei Säuglingen. Mschr. Kinderheilk. 120 (1972) 458-461
25. 25 Driscoll, D. J., P. C. Gillette, D. F. Duff, M. R. Nihill, H. P. Gutgesell, T. A. Vargo, C. H. B. Mullins, D. G. McNamara: Haemodynamic effects of dobutamine in children. Am. J. Cardiol. 43 (1979) 581-589
26. 26 Ehring, T., G. Heusch: Calciumantagonisten bei experimenteller Myokurdischämie und Reperfusion. In: Kübler, W., H. A. Tritthart (Hrsg.), Calciumantagonisten - Forschung und Klinik, Gegenwart und Zukunft. Steinkopff, Darmstadt (1996)
27. 27 Erdmann, E.: Digitalis - friend or foe? Eur. Heart J. 16 Suppl F (1995) 16-19
28. 28 Ewy, G. A.: Urgent parenteral digoxin therapy: a requiem. J. Am. Coll. Cardiol. 15 (1990) 1248-1249
29. 29 Federmann, M., O. M. Hess: Differentiation between systolic and diastolic dysfunction. Eur. Heart J. 15 Suppl D (1994) 2-6
30. 30 Garg, R., S. Yusuf: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. J. Am. Med. Assoc. 18 (1995) 1450-1456
31. 31 Gawaz, M. P., R. Schreiber, W. Vogt, Th. Genz, M. Kellner: Serumspiegel von digoxin-ähnlichen immunreaktiven Substanzen (DLIS) bei Neugeborenen im Verlauf der ersten beiden Lebenswochen, im Nabelschnurblut und bei Schwangeren zum Zeitpunkt der Geburt. Klin. Pädiatr. 202 (1990) 31-36
32. 32 Gheorghiade, M., D. Ferguson: Digoxin. A neurohormonal modulator in heart failure? Circulation 84 (1991) 2181-2186
33. 33 Gheorghiade, M., B. Pitt: Digitalis investigation group (DIG) trial: A stimulus for further research: Am. Heart J. 134 (1997) 3-12
34. 34 Harlan, W. R., A. Oberman, R. Grimm, R. A. Rosati: Chronic congestive heart failure in coronary artery disease: clinical criteria. Ann Intern. Med. 86 (1977) 133-138
35. 35 Hastreiter, A. R., R. L. van der Horst, E. Chow-Tung: Digitalis toxicity in infants and children. Pediatr. Cardiol. 5 (1984) 131-148
36. 36 Haque, W. A., J. Boehmer, C. S. Clemson, U. A. Leuenberger, D. H. Silber, L. I. Sinoway: Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J. Am. Coll. Cardiol. 27 (1996) 353-357
37. 37 Hobbins, S. M., R. S. Fowler, R. D. Rowe, A. G. Korey: Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch. Dis. Childh. 56 (1981) 934-938
38. 38 Hörnchen, H., M. Dreuw, U. Merz, M. C. Seghaye, S. Däbritz, G. Klein, B. J. Messmer: Intensivmedizinische Probleme nach kardiochirurgischen Eingriffen in der Neugeborenenperiode. Monatsschr. Kinderheilkd. 145 (1997) 880-885
39. 39 Hofstetter, R., D. Lang, G. von Bernuth: Effect of digoxin on left ventricular contractility in newborns and infants estimated by echocardiography. Eur. J. Cardiol. 9 (1979) 1-11
40. 40 Jonkman, F. A. M., G. De Jong, P. M. Fioretti: Growth hormone in the treatment of heart failure: a new tool for the future? Eur. Heart J. 18 (1997) 181-184
41. 41 Kallfelz, H. C., D. Reinhard: Zur Behandlung der Herzinsuffizienz im Säuglings-und Kindesalter mit einem Mischpräparat aus Digitalis-Lanata-Glykosiden. Therapie Gegenwart 110 (1971) 357-370
42. 42 Kimball, T. R., S. R. Daniels, R. A. Meyer, D. W. Hannon, P. Khoury, D. C. Schwartz: Relation of symptoms to contractility and defect size in infants with ventricular sepal defect 67 (1991) 1097-1102
43. 43 Kimball, T. R., S. R. Daniels, R. G. Weiss, R. A. Meyer, D. W. Hannon, F. C. Ryckmann, J. Tian, R. Shukla, D. C. Schwartz: Changes in cardiac function during extracorporeal membrane oxygenation for persistent pulmonary hypertension in the newborn infant. J. Pediatr. 118 (1991) 431-436
44. 44 Kimball, T. R., S. R. Daniels, R. Meyer, D. W. Hannon, J. Tian, R. Shukla, D. C. Schwartz: Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect. Am. J. Cardiol. 68 (1991) 1377-1382
45. 45 Lang, D., R. Hofstetter, G. von Bernuth: Postmortem tissue and plasma concentrations of digoxin in newborns and infants. Eur. J. Pediatr. 128 (1978) 151-161
46. 46 Leversha, A. M., N. J. Wilson, P. A. Clarkson, A. L. Calder, M. C. Ramage, J. M. Neutze: Efficacy and dosage of enalapril in congenital and acquired heart disease. Arch. Dis. Childh. 70 (1994) 35-39
47. 47 Levy, A. M., D. M. Leaman, J. S. Hanson: Effects of digoxin on systolic time intervals of neonates and infants. Circulation 46 (1972) 816-823
48. 48 Lindenbaum, J., D. G. Rund, V. P. Butler, D. Tse-Eng, J. R. Saha: Inactivation of digoxin by the gut flora: Reversal by antibiotic therapy. N. Engl. J. Med. 305 (1981) 789-794
49. 49 Madsen, B. K., J. F. Hansen, K. H. Stokholm, J. Brons, D. Husum, L. S. Mortensen: Chronic congestive heart failure. Description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur. Heart J. 15 (1994) 303-310
50. 50 McKee, P. A., W. P. Castelli, P. M. McNamara et al.: The natural history of congestive heart failure. The Framingham Study. N. Engl. J. Med. 26 (1971) 1441-1446
51. 51 Newton, G. E., J. H. Tong, A. M. Schofield, A. D. Baines, J. S. Floras, J. D. Parker: Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J. Am. Coll. Cardiol. 28 (1996) 155-161
52. 52 Osterziel, K. J., R. Dietz: Therapie der Herzinsuffizienz mit β-Blockern? Z. Kardiol. 86 (1997) 1-8
53. 53 Packer, M., M. Gheorghiade, J. B. Young, P. J. Costantini, K. F. Adams, R. J. Cody, K. L. Smith, L. van Voorhees, L. A. Gourley, M. K. Jolly for the RADIANCE Study: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. N. Engl. J. Med. 329 (1993) 1-7
54. 54 Park, M. K.: Use of digoxin in infants and children, with specific emphasis on dosage. J. Pediatr. 108 (1986) 871-877
55. 55 Richardson, H.: Frusemide in heart failure of infancy. Arch. Dis. Childhd. 46 (1971) 520-524
56. 56 Romero, T., J. Covell, W. F. Friedman: A comparison of pressure-volume relations of the fetal, newborn and adult heart. Am. J. Physiol. 222 (1972) 1285-1290
57. 57 Ross, R. D., R. O. Bollinger, W. W. Pinsky: Grading the severity of congestive heart failure in infants. Pediatr. Cardiol. 13 (1992) 72-75
58. 58 Schwinger, R. H. G.: Der Frank-Starling-Mechanismus. In: Erdmann, E. (Hrsg): Herzinsuffizienz - Ursachen, Pathophysiologie und Therapie. Wissenschaftl. Verlagsgsellschaft Stuttgart, 1995, S 95-101
59. 59 Seguchi, M., M. Nukazawa, K. Momma: Effect of enalapril on infants and children with congestive heart failure. Card. Young 2 (1992) 14-19
60. 60 Sigurdsson, A., K. Swedberg: Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use. Eur. Heart J. 16 Suppl. N (1995) 65-72
61. 61 SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Eng. J. Med. 325 (1991) 293-302
62. 62 Stern, H., J. Weil, T. Genz, W. Vogt, K. Bühlmeyer: Captopril in children with dilated cardiomyopathy: Acute and long-term effects in a prospective study of hemodynamic and hormonal effects. Pediatr. Cardiol. 11 (1990) 22-28
63. 63 Stopfkuchen, H., D. Schranz, R. Huth, B.-K. Jüngst: Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals. Eur. J. Pediatr. 146 (1987) 135-139
64. 64 Task Force on Heart Failure of the European Society of Cardiology: Guidelines for the diagnosis of heart failure. Eur. Heart J. 16 (1995) 741-751
65. 65 Taylor, S. H.: Refocus on diuretics in the treatment of heart failure. Eur. Heart J. 16 Suppl. F (1995) 7-15
66. 66 Teerlink, J. R., S. Z. Goldhaber, M. A. Pfeffer: An overview of contemporary etiologies of congestive heart failure. Am. Heart J. 121 (1991) 1852-1853
67. 67 Tisdale, J. E., M. Gheorghiade: Acute hemodynamic effects of digoxin alone or in combination with other vasoactive agents in patients with congestive heart failure. Am. J. Cardiol. 69 (1992) 34G-47G
68. 68 Tobin, J. R., R. C. Wetzel: Cardiovascular physiology and shock. In: Nichols, D. G., D. E. Cameron, W. J. Greeley, D. G. Lappe, R. M. Ungerleider, R. C. Wetzel (eds.): Critical heart disease in infants and children. Mosby, St. Louis (1995), pp. 17-74
69. 69 Unverferth, D. V., M. Blanford, R. E. Kates, C. V. Leier: Tolerance to dobutamine after a 72-hour continuous infusion. Am. J. Med. 69 (1980) 262
70. 70 Uretsky, B. F., J. B. Young, F. E. Shahidi, L. G. Yellen, M C. Harrison, M. K. Jolly on behalf of the PROVED Investigative Group. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the Proved Trial. J. Am. Coll. Cardiol. 22 (1993) 955-62
71. 71 Waagstein, F.: The role of β-blockers in dilated cardiomyopathy. Curr. Opin. Cardiol. 10 (1995) 322-331
72. 72 Waggoner A. D., S. Nouri, M. S. Schaffer, S.-C. Chen: Echocardiographic evaluation of left ventricular function, mass and wall stress in children with isolated VSD. Texas Heart Inst. J. 12 (1985) 163-170
73. 73 Ward, C. O., L. K. T. Lam: Bumetanide in heart failure in infancy. Arch. Dis. Childhd. 52 (1977) 877-882
74. 74 Webster, M. W. I., J. M. Neutze, A. L. Calder: Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr. Cardiol. 13 (1992) 129-135
75. 75 Wessel, A., P. Seiffert: Wirkungen von Amrinon bei Myokardinsuffizienz nach Herzoperationen im Kindesalter. Monatsschr. Kinderheilkd. 137 (1989) 712-715
76. 76 Wheeldon, N. M., P. Clarkson, T. M. MacDonald: Diastolic heart failure. Eur. Heart J. 15 (1994) 1689-1697
77. 77 Witte, M. K., J. E. Stork, L. J. Blumer: Diuretic therapeutics in the pediatric patient. Am. J. Cardiol. 57 (1986) 44A-53A
78. 78 Yoshikaw, M., T. Sato: Left ventricular end-systolic wall stress to volume relationship before and after surgical closure of VSD. Pediatr. Cardiol. 8 (1987) 93-98
79. 79 Yusuf, S., J. Wittes, K. Bailey, C. Furberg: Digitalis - a new controversy regarding an old drug. The pitfalls of inappropriate methods. Circulation 73 (1986) 14-18